133 related articles for article (PubMed ID: 34515327)
1. Wnt signaling promotes tumor development in part through phosphofructokinase 1 platelet isoform upregulation.
Jeon SM; Lim JS; Park SH; Lee JH
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34515327
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.
Lee JH; Liu R; Li J; Zhang C; Wang Y; Cai Q; Qian X; Xia Y; Zheng Y; Piao Y; Chen Q; de Groot JF; Jiang T; Lu Z
Nat Commun; 2017 Oct; 8(1):949. PubMed ID: 29038421
[TBL] [Abstract][Full Text] [Related]
3. EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.
Lee JH; Liu R; Li J; Wang Y; Tan L; Li XJ; Qian X; Zhang C; Xia Y; Xu D; Guo W; Ding Z; Du L; Zheng Y; Chen Q; Lorenzi PL; Mills GB; Jiang T; Lu Z
Mol Cell; 2018 Apr; 70(2):197-210.e7. PubMed ID: 29677490
[TBL] [Abstract][Full Text] [Related]
4. Mutual regulation between phosphofructokinase 1 platelet isoform and VEGF promotes glioblastoma tumor growth.
Lim JS; Shi Y; Park SH; Jeon SM; Zhang C; Park YY; Liu R; Li J; Cho WS; Du L; Lee JH
Cell Death Dis; 2022 Nov; 13(11):1002. PubMed ID: 36435833
[TBL] [Abstract][Full Text] [Related]
5. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D
Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886
[TBL] [Abstract][Full Text] [Related]
6. Phosphofructokinase 1 Platelet Isoform Enhances VEGF Expression in Part Through HIF-1α Up-regulation in Breast Cancer.
Lee JH
Anticancer Res; 2023 Jan; 43(1):75-84. PubMed ID: 36585185
[TBL] [Abstract][Full Text] [Related]
7. Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer.
Inaishi T; Shibata M; Ichikawa T; Kanda M; Hayashi M; Soeda I; Takeuchi D; Takano Y; Tsunoda N; Kodera Y; Kikumori T
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751415
[TBL] [Abstract][Full Text] [Related]
8. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer.
Wang F; Li L; Zhang Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236133
[TBL] [Abstract][Full Text] [Related]
9. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
[TBL] [Abstract][Full Text] [Related]
10. Phosphofructokinase 1 platelet isoform induces PD-L1 expression to promote glioblastoma immune evasion.
Wang S; Park SH; Lim JS; Park YY; Du L; Lee JH
Genes Genomics; 2022 Dec; 44(12):1509-1517. PubMed ID: 35917090
[TBL] [Abstract][Full Text] [Related]
11. Phosphofructokinase 1 Platelet Isoform Promotes β-Catenin Transactivation for Tumor Development.
Lee JH; Shao F; Ling J; Lu S; Liu R; Du L; Chung JW; Koh SS; Leem SH; Shao J; Xing D; An Z; Lu Z
Front Oncol; 2020; 10():211. PubMed ID: 32195176
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer.
Moon JS; Kim HE; Koh E; Park SH; Jin WJ; Park BW; Park SW; Kim KS
J Biol Chem; 2011 Jul; 286(27):23808-16. PubMed ID: 21586797
[TBL] [Abstract][Full Text] [Related]
13. Glycolysis regulator PFKP induces human melanoma cell proliferation and tumor growth.
Chen C; Zhang X
Clin Transl Oncol; 2023 Jul; 25(7):2183-2191. PubMed ID: 36792847
[TBL] [Abstract][Full Text] [Related]
14. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.
Kim NH; Cha YH; Lee J; Lee SH; Yang JH; Yun JS; Cho ES; Zhang X; Nam M; Kim N; Yuk YS; Cha SY; Lee Y; Ryu JK; Park S; Cheong JH; Kang SW; Kim SY; Hwang GS; Yook JI; Kim HS
Nat Commun; 2017 Feb; 8():14374. PubMed ID: 28176759
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
[TBL] [Abstract][Full Text] [Related]
16. p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP.
Huang Y; Xiong C; Wang C; Deng J; Zuo Z; Wu H; Xiong J; Wu X; Lu H; Hao Q; Zhou X
Cell Rep; 2023 Nov; 42(11):113426. PubMed ID: 37967006
[TBL] [Abstract][Full Text] [Related]
17. PFKP is highly expressed in lung cancer and regulates glucose metabolism.
Shen J; Jin Z; Lv H; Jin K; Jonas K; Zhu C; Chen B
Cell Oncol (Dordr); 2020 Aug; 43(4):617-629. PubMed ID: 32219704
[TBL] [Abstract][Full Text] [Related]
18. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
Chen L; Hu N; Wang C; Zhao H
Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
[TBL] [Abstract][Full Text] [Related]
19. PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.
Lang L; Chemmalakuzhy R; Shay C; Teng Y
Adv Exp Med Biol; 2019; 1134():243-258. PubMed ID: 30919341
[TBL] [Abstract][Full Text] [Related]
20. Silencing PFKP restrains the stemness of hepatocellular carcinoma cells.
Sha X; Wang K; Wang F; Zhang C; Yang L; Zhu X
Exp Cell Res; 2021 Oct; 407(1):112789. PubMed ID: 34418458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]